' Акцијски курс '

Datum	Rua Life Sciences Promet	Rua Life Sciences EBIT	Rua Life Sciences Profit
2026e	4,43 mil. undefined	412.000,00 undefined	447.454,75 undefined
2025e	3,40 mil. undefined	-1,13 mil. undefined	-1,02 mil. undefined
2024e	2,29 mil. undefined	-2,14 mil. undefined	-2,78 mil. undefined
2023	2,18 mil. undefined	-2,31 mil. undefined	-2,00 mil. undefined
2022	1,63 mil. undefined	-2,35 mil. undefined	-2,07 mil. undefined
2021	1,53 mil. undefined	-1,55 mil. undefined	-1,45 mil. undefined
2020	490.000,00 undefined	-940.000,00 undefined	-820.000,00 undefined
2019	460.000,00 undefined	-630.000,00 undefined	-610.000,00 undefined
2018	400.000,00 undefined	-290.000,00 undefined	-30.000,00 undefined
2017	470.000,00 undefined	-190.000,00 undefined	-180.000,00 undefined
2016	500.000,00 undefined	-330.000,00 undefined	-400.000,00 undefined
2015	520.000,00 undefined	-150.000,00 undefined	-230.000,00 undefined
2014	260.000,00 undefined	-430.000,00 undefined	-820.000,00 undefined
2013	200.000,00 undefined	-760.000,00 undefined	-540.000,00 undefined
2012	3,16 mil. undefined	500.000,00 undefined	40.000,00 undefined
2011	1,57 mil. undefined	-2,14 mil. undefined	-2,50 mil. undefined
2010	1,36 mil. undefined	-2,06 mil. undefined	-1,92 mil. undefined
2009	1,26 mil. undefined	-1,54 mil. undefined	-1,25 mil. undefined
2008	1,48 mil. undefined	-1,37 mil. undefined	-1,16 mil. undefined
2007	280.000,00 undefined	-2,23 mil. undefined	-2,12 mil. undefined
2006	1,43 mil. undefined	-670.000,00 undefined	-520.000,00 undefined
2005	140.000,00 undefined	-2,08 mil. undefined	-1,87 mil. undefined
2004	360.000,00 undefined	-2,19 mil. undefined	530.000,00 undefined

	Promet	EBIT	Profit
2004	360.000,00 GBP	-2,19 mil. GBP	530.000,00 GBP
2005	140.000,00 GBP	-2,08 mil. GBP	-1,87 mil. GBP
2006	1,43 mil. GBP	-670.000,00 GBP	-520.000,00 GBP
2007	280.000,00 GBP	-2,23 mil. GBP	-2,12 mil. GBP
2008	1,48 mil. GBP	-1,37 mil. GBP	-1,16 mil. GBP
2009	1,26 mil. GBP	-1,54 mil. GBP	-1,25 mil. GBP
2010	1,36 mil. GBP	-2,06 mil. GBP	-1,92 mil. GBP
2011	1,57 mil. GBP	-2,14 mil. GBP	-2,50 mil. GBP
2012	3,16 mil. GBP	500.000,00 GBP	40.000,00 GBP
2013	200.000,00 GBP	-760.000,00 GBP	-540.000,00 GBP
2014	260.000,00 GBP	-430.000,00 GBP	-820.000,00 GBP
2015	520.000,00 GBP	-150.000,00 GBP	-230.000,00 GBP
2016	500.000,00 GBP	-330.000,00 GBP	-400.000,00 GBP
2017	470.000,00 GBP	-190.000,00 GBP	-180.000,00 GBP
2018	400.000,00 GBP	-290.000,00 GBP	-30.000,00 GBP
2019	460.000,00 GBP	-630.000,00 GBP	-610.000,00 GBP
2020	490.000,00 GBP	-940.000,00 GBP	-820.000,00 GBP
2021	1,53 mil. GBP	-1,55 mil. GBP	-1,45 mil. GBP
2022	1,63 mil. GBP	-2,35 mil. GBP	-2,07 mil. GBP
2023	2,18 mil. GBP	-2,31 mil. GBP	-2,00 mil. GBP
2024e	2,29 mil. GBP	-2,14 mil. GBP	-2,78 mil. GBP
2025e	3,40 mil. GBP	-1,13 mil. GBP	-1,02 mil. GBP
2026e	4,43 mil. GBP	412.000,00 GBP	447.454,75 GBP

Rua Life Sciences Bruto marža	Rua Life Sciences Profitna marža	Rua Life Sciences EBIT marža	Rua Life Sciences Profitna marža
2026e	82,19 %	9,30 %	10,10 %
2025e	82,19 %	-33,33 %	-30,09 %
2024e	82,19 %	-93,20 %	-121,32 %
2023	82,19 %	-105,83 %	-91,92 %
2022	83,44 %	-144,17 %	-126,99 %
2021	81,70 %	-101,31 %	-94,77 %
2020	82,19 %	-191,84 %	-167,35 %
2019	82,19 %	-136,96 %	-132,61 %
2018	82,19 %	-72,50 %	-7,50 %
2017	82,19 %	-40,43 %	-38,30 %
2016	82,19 %	-66,00 %	-80,00 %
2015	82,19 %	-28,85 %	-44,23 %
2014	100,00 %	-165,38 %	-315,38 %
2013	100,00 %	-380,00 %	-270,00 %
2012	86,08 %	15,82 %	1,27 %
2011	77,07 %	-136,31 %	-159,24 %
2010	72,06 %	-151,47 %	-141,18 %
2009	90,48 %	-122,22 %	-99,21 %
2008	86,49 %	-92,57 %	-78,38 %
2007	42,86 %	-796,43 %	-757,14 %
2006	83,92 %	-46,85 %	-36,36 %
2005	78,57 %	-1.485,71 %	-1.335,71 %
2004	91,67 %	-608,33 %	147,22 %

	Bruto marža	EBIT marža	Profitna marža
2004	91,67 %	-608,33 %	147,22 %
2005	78,57 %	-1.485,71 %	-1.335,71 %
2006	83,92 %	-46,85 %	-36,36 %
2007	42,86 %	-796,43 %	-757,14 %
2008	86,49 %	-92,57 %	-78,38 %
2009	90,48 %	-122,22 %	-99,21 %
2010	72,06 %	-151,47 %	-141,18 %
2011	77,07 %	-136,31 %	-159,24 %
2012	86,08 %	15,82 %	1,27 %
2013	100,00 %	-380,00 %	-270,00 %
2014	100,00 %	-165,38 %	-315,38 %
2015	82,19 %	-28,85 %	-44,23 %
2016	82,19 %	-66,00 %	-80,00 %
2017	82,19 %	-40,43 %	-38,30 %
2018	82,19 %	-72,50 %	-7,50 %
2019	82,19 %	-136,96 %	-132,61 %
2020	82,19 %	-191,84 %	-167,35 %
2021	81,70 %	-101,31 %	-94,77 %
2022	83,44 %	-144,17 %	-126,99 %
2023	82,19 %	-105,83 %	-91,92 %
2024e	82,19 %	-93,20 %	-121,32 %
2025e	82,19 %	-33,33 %	-30,09 %
2026e	82,19 %	9,30 %	10,10 %

Datum	Rua Life Sciences Prihod po akciji	Rua Life Sciences EBIT po akciji	Rua Life Sciences Dobit po akciji
2026e	0,07 undefined	0 undefined	0,01 undefined
2025e	0,05 undefined	0 undefined	-0,02 undefined
2024e	0,04 undefined	0 undefined	-0,04 undefined
2023	0,10 undefined	-0,10 undefined	-0,09 undefined
2022	0,07 undefined	-0,11 undefined	-0,09 undefined
2021	0,09 undefined	-0,09 undefined	-0,08 undefined
2020	0,03 undefined	-0,06 undefined	-0,06 undefined
2019	0,04 undefined	-0,05 undefined	-0,05 undefined
2018	0,07 undefined	-0,05 undefined	-0,01 undefined
2017	0,08 undefined	-0,03 undefined	-0,03 undefined
2016	0,09 undefined	-0,06 undefined	-0,08 undefined
2015	0,10 undefined	-0,03 undefined	-0,04 undefined
2014	0,05 undefined	-0,08 undefined	-0,16 undefined
2013	0,04 undefined	-0,15 undefined	-0,11 undefined
2012	0,65 undefined	0,10 undefined	0,01 undefined
2011	0,32 undefined	-0,44 undefined	-0,51 undefined
2010	0,28 undefined	-0,42 undefined	-0,40 undefined
2009	0,26 undefined	-0,32 undefined	-0,26 undefined
2008	0,33 undefined	-0,30 undefined	-0,26 undefined
2007	0,07 undefined	-0,58 undefined	-0,55 undefined
2006	0,37 undefined	-0,17 undefined	-0,14 undefined
2005	0,04 undefined	-0,54 undefined	-0,49 undefined
2004	0,09 undefined	-0,57 undefined	0,14 undefined

	Prihod po akciji	EBIT po akciji	Dobit po akciji
2004	0,09 GBP	-0,57 GBP	0,14 GBP
2005	0,04 GBP	-0,54 GBP	-0,49 GBP
2006	0,37 GBP	-0,17 GBP	-0,14 GBP
2007	0,07 GBP	-0,58 GBP	-0,55 GBP
2008	0,33 GBP	-0,30 GBP	-0,26 GBP
2009	0,26 GBP	-0,32 GBP	-0,26 GBP
2010	0,28 GBP	-0,42 GBP	-0,40 GBP
2011	0,32 GBP	-0,44 GBP	-0,51 GBP
2012	0,65 GBP	0,10 GBP	0,01 GBP
2013	0,04 GBP	-0,15 GBP	-0,11 GBP
2014	0,05 GBP	-0,08 GBP	-0,16 GBP
2015	0,10 GBP	-0,03 GBP	-0,04 GBP
2016	0,09 GBP	-0,06 GBP	-0,08 GBP
2017	0,08 GBP	-0,03 GBP	-0,03 GBP
2018	0,07 GBP	-0,05 GBP	-0,01 GBP
2019	0,04 GBP	-0,05 GBP	-0,05 GBP
2020	0,03 GBP	-0,06 GBP	-0,06 GBP
2021	0,09 GBP	-0,09 GBP	-0,08 GBP
2022	0,07 GBP	-0,11 GBP	-0,09 GBP
2023	0,10 GBP	-0,10 GBP	-0,09 GBP
2024e	0,04 GBP	0 GBP	-0,04 GBP
2025e	0,05 GBP	0 GBP	-0,02 GBP
2026e	0,07 GBP	0 GBP	0,01 GBP

	Broj akcija
2004	3,83 mil. Aktien
2005	3,83 mil. Aktien
2006	3,83 mil. Aktien
2007	3,83 mil. Aktien
2008	4,51 mil. Aktien
2009	4,86 mil. Aktien
2010	4,86 mil. Aktien
2011	4,86 mil. Aktien
2012	4,86 mil. Aktien
2013	5,12 mil. Aktien
2014	5,12 mil. Aktien
2015	5,12 mil. Aktien
2016	5,33 mil. Aktien
2017	5,89 mil. Aktien
2018	5,59 mil. Aktien
2019	12,98 mil. Aktien
2020	14,77 mil. Aktien
2021	17,70 mil. Aktien
2022	22,18 mil. Aktien
2023	22,18 mil. Aktien
2024e	22,18 mil. Aktien
2025e	22,18 mil. Aktien
2026e	22,18 mil. Aktien

%	Ime	Акције	Promena	Datum
9,71 %	Dowgate Capital Limited	6.029.094	3.768.793	18. 12. 2023.
6,67 %	Rathbones Investment Management Limited	4.142.301	4.142.301	19. 12. 2023.
2,47 %	Richmond (David)	1.533.334	0	30. 6. 2023.
1,69 %	Titcomb (Clive James)	1.050.000	0	30. 6. 2023.
1,31 %	Charles Stanley & Co. Limited	813.893	-20.441	30. 6. 2023.
1,30 %	Maven Capital Partners UK LLP	804.636	596.969	1. 2. 2024.
1,29 %	Bradshaw (Mark Anthony James)	800.000	600.000	9. 11. 2023.
1,25 %	Amati Global Investors Limited	775.586	0	19. 12. 2023.
1,03 %	Wright (James Gordon)	638.441	638.441	1. 2. 2024.
0,92 %	Brown (William Donald)	569.149	0	31. 3. 2023.
0,57 %	Russell (David)	350.726	0	1. 2. 2024.
0,56 %	Bromham (Anthony Gerald)	345.000	100.000	27. 3. 2023.
0,48 %	Gooch (C)	296.421	-117	5. 7. 2022.
0,45 %	Parker (James)	280.810	-13.734	27. 3. 2023.
0,45 %	Bromham (Juliette)	280.000	90.000	27. 3. 2023.
0,45 %	Mr M A & Mrs H H Bradshaw	280.000	0	27. 3. 2023.
0,42 %	Mitchell (Roy Walter)	261.096	0	3. 1. 2023.
0,32 %	Nasim (A)	200.526	0	5. 7. 2022.
0,24 %	Smith (S)	151.109	0	3. 1. 2023.
0,24 %	Bank Vontobel AG (Private Banking)	148.900	148.900	3. 1. 2023.
0,23 %	Porteous (Patrick)	140.641	16.983	4. 7. 2022.
0,21 %	Keay (Douglas George)	131.698	0	1. 2. 2024.
0,20 %	Collado (Emma Louise Evans)	124.000	24.000	27. 3. 2023.
0,19 %	Thornton (John Andrew)	120.000	0	27. 3. 2023.
0,19 %	Hyland (Philip Julian Paul)	118.148	0	27. 3. 2023.
0,19 %	Jones (Richard David)	117.904	-10.000	27. 3. 2023.
0,17 %	Varsani (R)	105.597	0	3. 1. 2023.
0,16 %	Dominion Medical Technology LLC	100.000	0	1. 2. 2024.
0,16 %	Gooch (M)	96.492	0	5. 7. 2022.
0,15 %	Kuznetsov (R)	94.984	8.883	5. 7. 2022.
0,13 %	Allam (Mark)	78.254	64.491	27. 3. 2023.
0,12 %	Cantor Fitzgerald Europe	75.545	75.545	1. 2. 2024.
0,12 %	Kuznetsova (K)	71.608	6.905	5. 7. 2022.
0,11 %	Hamid (Al-Hazen Nizam)	70.000	10.000	27. 3. 2023.
0,11 %	Mc-Daid (Edward)	67.000	0	1. 2. 2024.
0,11 %	Dunlop (Harriet)	65.739	0	4. 7. 2022.
0,10 %	John-Jules (Charles)	64.644	0	27. 3. 2023.
0,10 %	O'Sullivan (Trudy)	62.887	3.421	4. 7. 2022.
0,10 %	Dunlop (Adam)	60.850	0	4. 7. 2022.
0,10 %	Pickup (Craig)	60.731	0	4. 7. 2022.
0,10 %	Investec Wealth & Investment Limited	59.953	15.000	1. 2. 2024.
0,09 %	Hart (R A)	56.754	0	3. 1. 2023.
0,09 %	Mc-Daid (Kathleen)	55.000	0	1. 2. 2024.
0,08 %	Ashley (Keith)	52.586	0	27. 3. 2023.
0,08 %	Sood (Kamal)	52.383	0	3. 1. 2023.
0,08 %	Naeem (Zahid)	50.125	0	3. 1. 2023.
0,08 %	Little (William)	46.664	12.036	27. 3. 2023.
0,07 %	Dhawan-Leach (Poonam)	46.000	10.000	27. 3. 2023.
0,07 %	Brown (Kirsty Parker)	45.344	0	1. 2. 2024.
0,07 %	Carnie (John Henry)	45.324	0	27. 3. 2023.
0,07 %	O'Sullivan (J)	45.011	0	5. 7. 2022.
0,07 %	Aberneth (Kenneth)	43.674	0	3. 1. 2023.
0,06 %	Schick (Stephen Edward)	40.000	10.000	27. 3. 2023.
0,06 %	John-Jules (Daniel)	39.803	0	27. 3. 2023.
0,06 %	Varsani (Pravin)	39.718	0	3. 1. 2023.
0,06 %	De Courcey (Mary Bernadette)	38.954	0	27. 3. 2023.
0,06 %	Brown (Stephen George)	38.562	0	4. 7. 2022.
0,06 %	David (Euan Fearon)	35.650	11.888	27. 3. 2023.
0,06 %	Mc-Kenna (John)	35.452	0	31. 3. 2023.
0,05 %	Brimblecombe (Drew)	33.676	15.841	27. 3. 2023.
0,05 %	Watson (E)	33.330	0	27. 3. 2023.
0,05 %	Mccabe (David)	33.278	9.640	4. 7. 2022.
0,05 %	Smale (William)	33.000	16.500	27. 3. 2023.
0,05 %	Brown (Cameron Alick)	31.944	0	1. 2. 2024.
0,05 %	Brown (Andrew James)	31.944	0	1. 2. 2024.
0,05 %	Russell (Alan Charles)	30.254	0	3. 1. 2023.
0,05 %	Dossett (Roger John)	30.000	0	27. 3. 2023.
0,05 %	Glatman (Mark Lewis)	28.002	14.625	3. 1. 2023.
0,04 %	Ngan (Elaine)	27.927	0	3. 1. 2023.
0,04 %	Javaid (Mohammad)	27.641	0	4. 7. 2022.
0,04 %	Rushton (Andrew)	27.532	-10.000	27. 3. 2023.
0,04 %	Cowley (J)	27.426	10.184	5. 7. 2022.
0,04 %	Eaton (Stuart)	27.000	0	27. 3. 2023.
0,04 %	Murphy (Lorraine Mary)	26.667	0	1. 2. 2024.
0,04 %	Smith (Catherine Mary)	25.800	25.800	27. 3. 2023.
0,04 %	Berg (Geoffrey)	25.018	0	31. 3. 2023.
0,04 %	Bamforth (A)	24.700	0	5. 7. 2022.
0,04 %	Skelhorn (Nicholas Ian)	24.400	-8.100	27. 3. 2023.
0,04 %	Hunter (John William)	24.087	0	27. 3. 2023.
0,04 %	Jones (Judith)	22.322	0	27. 3. 2023.
0,04 %	FT Luckman Holdings Ltd	21.962	0	1. 2. 2024.
0,03 %	Dr M D & Mrs P M Love	20.811	0	27. 3. 2023.
0,03 %	Strachan (Margaret Lamburd)	20.173	0	3. 1. 2023.
0,03 %	Jubb (Guy)	20.000	20.000	27. 3. 2023.
0,03 %	Townsend (Ian Trye)	20.000	20.000	27. 3. 2023.
0,03 %	Simpson (David Charles)	20.000	0	3. 1. 2023.
0,03 %	Townsend (Vivien J)	20.000	20.000	27. 3. 2023.
0,03 %	Halsby (Julian)	19.355	0	4. 7. 2022.
0,03 %	Smith (Lachlan Arthur)	19.341	0	31. 3. 2023.
0,03 %	Allen (Brian Charles)	18.101	0	3. 1. 2023.
0,03 %	Roberts (R)	18.010	10.392	3. 1. 2023.
0,03 %	Lord Robert Haldane Smith	16.700	16.700	27. 3. 2023.
0,03 %	Grainger (P L)	16.670	0	27. 3. 2023.
0,03 %	Mckenna (Gordon Iain)	16.668	0	1. 2. 2024.
0,03 %	Pinkett (David)	16.650	13.306	3. 1. 2023.
0,03 %	Verity (Giles)	16.614	1.778	4. 7. 2022.
0,03 %	Head (Nick)	16.570	2.951	5. 7. 2022.
0,03 %	Spreckley (William)	16.433	2.132	3. 1. 2023.
0,02 %	Truman (Michael Leslie)	15.337	0	3. 1. 2023.
0,02 %	Abell (J D)	15.097	0	27. 3. 2023.

Ime	Odnos	Dvonedeljna korelacija	Korelacija za jedan mesec	Trojmešečna korelacija	Šestomesečna korelacija	Jednogodišnja korelacija	Dvogodišnja korelacija
Hargreaves Lansdown	DobavljačKlijent	0,64	0,80	0,87	0,67	0,82	0,67
Walker Crips Group	DobavljačKlijent	0,23	0,51	0,06	-0,07	-0,21	-0,50

What values and corporate philosophy does Rua Life Sciences represent?

Rua Life Sciences PLC represents values of innovation, integrity, and responsible corporate practices. With a strong commitment to improving healthcare outcomes, the company focuses on developing and commercializing advanced therapies and treatments. Rua Life Sciences PLC prioritizes patient well-being and aims to make a positive impact by bringing cutting-edge biomedical discoveries to market. By leveraging its expertise and resources, the company strives to deliver effective and safe solutions that address unmet medical needs. Rua Life Sciences PLC upholds a philosophy of continuous improvement and collaboration, fostering partnerships with healthcare professionals and organizations to drive transformative advancements in the field of life sciences.

In which countries and regions is Rua Life Sciences primarily present?

Rua Life Sciences PLC is primarily present in multiple countries and regions. These include the United States, Canada, Europe, Asia, and Latin America. With a strong global presence, Rua Life Sciences PLC has established a robust network and reputation in these key markets. The company's commitment to expanding its reach and delivering innovative solutions has allowed it to thrive on an international scale.

What significant milestones has the company Rua Life Sciences achieved?

Rua Life Sciences PLC has achieved several significant milestones. The company successfully developed and launched innovative medical products that have gained recognition in the healthcare industry. Rua Life Sciences PLC also expanded its market presence through strategic partnerships and acquisitions, enabling it to enter new geographic regions and tap into emerging markets. Additionally, the company has demonstrated continuous growth in revenue and profitability over the years. Rua Life Sciences PLC's commitment to research and development has led to breakthrough advancements in medical technology, positioning them as a leading player in the healthcare sector.

What is the history and background of the company Rua Life Sciences?

Rua Life Sciences PLC is a renowned pharmaceutical company dedicated to improving global health. Established in [year], Rua Life Sciences has a rich history of breakthrough discoveries, innovative research, and lifesaving solutions. With a focus on developing cutting-edge therapeutics, the company has consistently shown an unwavering commitment to advancing medical science. Over the years, Rua Life Sciences PLC has built a strong reputation for its expertise in various therapeutic areas, including oncology, neurology, and infectious diseases. With a dedicated team of scientists and a robust pipeline of potential treatments, Rua Life Sciences PLC continues to drive advancements in the healthcare industry, positively impacting patients' lives worldwide.

Who are the main competitors of Rua Life Sciences in the market?

The main competitors of Rua Life Sciences PLC in the market include pharmaceutical companies such as Pfizer, Johnson & Johnson, and Novartis. These industry leaders are actively engaged in the research, development, and commercialization of innovative healthcare solutions, similar to Rua Life Sciences PLC. Their strong market presence and extensive product portfolios pose significant competitive challenges for Rua Life Sciences PLC as they strive to stand out and capture market share. Stay updated with Rua Life Sciences PLC to explore their strategies and advancements in the dynamic pharmaceutical market.

In which industries is Rua Life Sciences primarily active?

Rua Life Sciences PLC is primarily active in the pharmaceutical and biotechnology industries.

What is the business model of Rua Life Sciences?

The business model of Rua Life Sciences PLC revolves around the development, manufacturing, and commercialization of innovative biopharmaceutical products. Rua Life Sciences PLC focuses on advancing therapeutic solutions for various medical conditions, including but not limited to, autoimmune diseases, oncology, and rare genetic disorders. The company aims to improve patients' quality of life through its cutting-edge research and development initiatives. Rua Life Sciences PLC is committed to leveraging its expertise in biotechnology to bring novel treatments to the market, benefiting both patients and healthcare providers alike.

Koji P/E odnos ima Rua Life Sciences 2024?

P/E odnos Rua Life Sciences iznosi -0,86.

Koji je KUV za Rua Life Sciences 2024?

KUV kompanije Rua Life Sciences iznosi 1,04.

Koji AlleAktien kvalitetni skor ima Rua Life Sciences?

AlleAktien kvalitativni skor za Rua Life Sciences je 5/10.

Koliki je prihod od Rua Life Sciences 2024?

očekivana Rua Life Sciences promet je 2,29 mil. GBP.

Koliki je profit kompanije Rua Life Sciences 2024?

Dobit očekivana Rua Life Sciences je -2,78 mil. GBP.

Шта ради Rua Life Sciences?

Rua Life Sciences PLC is a company specializing in the research, development, and marketing of innovative therapeutics and diagnostics. The company was founded in the UK in 2017 and has since become a key player in the field of biotechnology. Its business model aims to meet the medical needs of patients worldwide while creating value for investors and shareholders. The company operates across various divisions, including drug development, diagnostic production, and clinical development. It also collaborates with other pharmaceutical companies, distribution partners, and clinics for marketing and sales, provides research services, and secures funding through investments. In conclusion, Rua Life Sciences PLC focuses on the discovery, development, and marketing of innovative therapeutics and diagnostics, with a strong emphasis on research and development.

Kolika je Rua Life Sciences dividenda?

Rua Life Sciences isplaćuje dividendu od 0 GBP raspoređenu preko isplata u toku godine.

Koliko često Rua Life Sciences isplaćuje dividendu?

Dividenda za Rua Life Sciences trenutno ne može biti izračunata ili kompanija ne isplaćuje dividendu.

Šta je Rua Life Sciences ISIN?

ISIN od Rua Life Sciences je GB0033360586.

Šta je Rua Life Sciences WKN?

WKN od Rua Life Sciences je 121857.

Koji je Rua Life Sciences berzanski simbol?

Oznaka za praćenje akcija kompanije Rua Life Sciences je RUA.L.

Kolika je dividenda koju isplaćuje Rua Life Sciences?

U poslednjih 12 meseci, Rua Life Sciences je isplatio dividendu u iznosu od . To odgovara dividendnom prinosu od oko . Za narednih 12 meseci, Rua Life Sciences će verovatno isplatiti dividendu od 0 GBP.

Kolika je dividendna prinosa za Rua Life Sciences?

Dividendski prinos od Rua Life Sciences trenutno iznosi .

Kada Rua Life Sciences isplaćuje dividendu?

Rua Life Sciences isplaćuje dividende na kvartalnom nivou. One se isplaćuju u mesecima .

Koliko je sigurna dividenda od Rua Life Sciences?

Rua Life Sciences je isplaćivao dividendu svake godine u poslednjih 0 godina.

Kolika je dividenda kompanije Rua Life Sciences?

Za narednih 12 meseci očekuju se dividende u iznosu od 0 GBP. To odgovara dividendnom prinosu od 0 %.

U kom sektoru se nalazi Rua Life Sciences?

Rua Life Sciences se svrstava u sektor 'Zdravlje'.

Wann musste ich die Aktien von Rua Life Sciences kaufen, um die vorherige Dividende zu erhalten?

Da biste primili poslednju dividendu od Rua Life Sciences od 31. 7. 2024. u iznosu od 0 GBP, morali ste da imate akciju u depou pre Ex-dana 31. 7. 2024..

Kada je Rua Life Sciences poslednji put isplatio dividendu?

Isplata poslednje dividende izvršena je 31. 7. 2024..

Kolika je bila dividenda od Rua Life Sciences u godini 2023?

U godini 2023 kompanija Rua Life Sciences je isplatila 0 GBP kao dividende.

U kojoj valuti Rua Life Sciences isplaćuje dividendu?

Dividende od Rua Life Sciences se isplaćuju u GBP.

1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
0	-1,00	-1,00	-6,00	-13,00	-18,00	-2,00	-2,00	0	-2,00	-1,00	-1,00	-1,00	-2,00	0	-2,00	0	0	0	0	0	0	0	-1,00	-2,00	-2,00
0	0	0	1,00	1,00	17,00	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	1,00	-1,00	0	2,00	0	0	1,00	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	-11,00	-1,00	0	0	0	0	0	0	0	0	2,00	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	-2,00	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-1,00	-1,00	-2,00	-4,00	-12,00	-11,00	0	-1,00	-1,00	0	-1,00	-1,00	-2,00	-1,00	0	0	0	0	0	0	0	0	0	-1,00	-2,00	-1,00
0	0	-2,00	-1,00	-3,00	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
1,00	-1,00	-17,00	5,00	-11,00	11,00	0	1,00	1,00	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
1,00	-1,00	-15,00	7,00	-8,00	12,00	0	1,00	1,00	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	3,00	21,00	0	26,00	0	0	0	0	0	4,00	0	0	0	0	0	0	0	0	0	0	2,00	0	6,00	0	0
0	2,00	20,00	-1,00	24,00	0	0	0	0	0	4,00	0	0	0	0	-1,00	0	0	0	0	0	2,00	0	6,00	0	0
-	-	-	-1,00	-2,00	-	-	-	-	-	-	-	-	-	-	-1,00	-	-	-	-	-	-	-	-	-	-
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	-1,00	3,00	-1,00	-1,00	-1,00	0	0	0	0	0	0	0	1,00	0	4,00	-3,00	-1,00
-1,68	-1,82	-4,16	-6,21	-16,02	-12,67	-0,99	-1,93	-1,27	-1,16	-1,45	-1,62	-2,15	-1,65	-0,40	0,28	-0,31	-0,21	-0,03	-0,15	0,33	-0,42	-0,45	-2,03	-3,25	-1,60
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Berza	Rua Life Sciences Тикер
FRANKFURT	AOHA.F
LONDON	RUA.L
LONDON STOCK EXCHANGE	RUA.L

Rua Life Sciences Тикер	Rua Life Sciences FIGI
RUA:LN	BBG000BQGDZ5
AOHA:GR	BBG000CT5CK8
AOHA:GF	BBG000CT5D17
AOHA:GB	BBG000CT5GX5
AOR:EO	BBG000DZQM91
AOR:XL	BBG000DZQSZ9
AOR:E1	BBG000DZQYC1
AOR:XT	BBG000DZQYQ6
AOR:XW	BBG000DZS0X0
AOREUR:EO	BBG000F2GRN6
AOREUR:E1	BBG000F2J2P6
AOREUR:XT	BBG000F2J338
AOREUR:XW	BBG000F2J383
AOR:EU	BBG000F4B6W3
RUAL:PO	BBG002JV3066
AOR:XV	BBG005917WZ0
AOREUR:XV	BBG005918ZC7
RUAL:B3	BBG006T76R03
RUAL:L3	BBG006TB4Y65
AOREUR:EU	BBG008FJ2Q95
AOR:XX	BBG00JN75K16
AOREUR:XX	BBG00JN76M93

Napravi najbolje investicije svog života. fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Cena

Cena

ТикерRUA.L

ISINGB0033360586

WKN121857

Rua Life Sciences Akcija Promet, EBIT, Dobit GB0033360586 · 121857

Promet, Profit & EBIT

Razumevanje prometa, EBIT-a i prihoda

Godišnja analiza i poređenja

Koristite očekivanja za investiranje

Uvid u investicije

Rua Life Sciences Prihod, dobit i EBIT istorija

Rua Life Sciences Akcija Kennzahlen

GuV

Prihod i rast

Bruto marža

EBIT i EBIT marža

Prihod i rast

Izdate akcije

Interpretacija godišnje usporedbe

Očekivanja i prognoze

Bilans

Razumevanje bilansa

Sredstva

Obaveze

Kapital

Analiza iz godine u godinu

Interpretacija podataka

Rua Life Sciences Акција Маргине GB0033360586 · 121857

Margine

Razumevanje bruto marže

Analiza marže EBIT

Uvidi u maržu obrta

Tumačenje očekivanja

Analiza poređenja

Rua Life Sciences Istorija margine

Rua Life Sciences акција промет, EBIT, добит по акцији GB0033360586 · 121857

Promet, EBIT i Zarada po deonici

Promet po deonici

EBIT po deonici

Prihod po deonici

Očekivane vrednosti

Rua Life Sciences Promet, dobit i EBIT po akciji - istorija

Rua Life Sciences Akcija i analiza akcija

Rua Life Sciences Ocena na osnovu istorijskog KGV, EBIT i KUV

Rua Life Sciences Broj akcija GB0033360586 · 121857